[Tryptophan and its metabolites in renal allograft recipients]. 2009

Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
I Klinika Chirurgii Ogólnej i Endokrynologicznej, Uniwersytet Medyczny w Białymstoku. mpiotr@umwb.edu.pl

OBJECTIVE Disturbances in amino acids metabolism are common in chronic renal failure and subside partially after renal tranplantation. Tryptophan (TRP) is one of the most important exogenous amino acids. Its main derivative is L-kynurenine (KYN). Disorders in the TRP metabolism via kynurenine pathway may lead to neurologic disturbances, hypertension and anaemia. The aim of this study was to assess peripheral kynurenine pathway in 28 renal allograft recipients (RAR) (12 women and 16 men) in comparison to 10 hemodialysed patients with chronic renal failure (CRF) and 10 healthy subjects. METHODS TRP, KYN, 3-hydroxykynurenine (3-HKYN), kyn-urenic acid (KYNA) and quinolinic acid (QA) were determined in plasma using high performance liquid chromatography technique. RESULTS The plasma concentration of tryptophan in RAR was not significantly different from the control group, but it was almost twice higher than in CRF. There was an increase in most of kynurenine metabolites in RAR as compared to healthy subjects, although not as high as in CRF. We found a significant negative correlation between TRP and serum concentration of urea and creatinine as well as a positive correlation with GFR. CONCLUSIONS Kidney transplantation tends to normalize TRP level and markedly lowers blood concentration of kynurenine and its main derivatives. A significant negative correlation was found between TRP level and the concentration of urea and creatinine. Lowering of the KYN metabolites level may play a role in lessening uremic neurological symptomes as well as hypertension and anemia in kidney graft recipients.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007737 Kynurenine A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
January 1989, Pharmacology,
Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
September 1986, Transplantation,
Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
July 1980, The American journal of clinical nutrition,
Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
December 1999, Transplantation proceedings,
Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
January 1999, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
January 1974, Progress in experimental tumor research,
Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
April 1978, Archives of surgery (Chicago, Ill. : 1960),
Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
October 1994, Transplantation,
Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
June 1996, Transplantation proceedings,
Piotr Myśliwiec, and Hanna Myśliwiec, and Dariusz Pawlak, and Jacek Dadan, and Włodzimierz Buczko, and Krystyna Pawlak
January 1982, American journal of nephrology,
Copied contents to your clipboard!